Radial Artery Occlusion: Is Ethnicity a Real Risk Factor?
"Unpacking the complexities of RAO after heart catheterization and whether Japanese ethnicity truly increases the risk."
Radial artery occlusion (RAO) is a known complication following transradial heart catheterization, a common procedure where a catheter is inserted through the radial artery to reach the heart. Medical device companies have engineered slender sheaths, like the Glidesheath Slender series, to reduce the incidence of RAO by minimizing the profile of the inserted instruments. But how effective are these measures across different populations?
A study known as the Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial, sought to compare the efficacy of the 6Fr Glidesheath Slender with the standard 5Fr sheath in preventing RAO. While the initial results didn't establish the slender sheath's noninferiority, an intriguing subgroup analysis revealed a potential disparity between Japanese and non-Japanese participants.
In this analysis, Japanese patients experienced a higher incidence of RAO compared to their non-Japanese counterparts. Moreover, the 6Fr slender sheath appeared to be associated with a greater risk of RAO in Japanese patients, a finding that raises important questions about the role of ethnicity in vascular outcomes.
Incidence Depends on Assessment
Radial artery occlusion (RAO) is described as a common complication after transradial procedures, and studies have examined its incidence after transradial access for percutaneous coronary intervention (PCI). The supplied study summaries do not give an incidence figure for those individual studies. A separate source notes that reported rates vary across the literature, so these materials do not support a single overall rate.
Prevention Guidance, No Standard Treatment Protocol
A 2019 review offers recommendations intended to prevent periprocedural RAO and preserve the possibility of repeat catheterization or coronary artery bypass grafting. A 2025 review instead summarizes available RAO treatment strategies, noting that the literature lacks a standardized treatment protocol. A 2026 report likewise says revascularization protocols are not standardized and that centers may use different techniques.
RAO as a Limit on Future Arterial Use
A 2016 review examined the incidence and factors influencing RAO after transradial interventions, describing how occlusion can limit the radial artery as a future access site or arterial conduit. Other supplied material identifies prolonged high-pressure compression, repeated arterial access, and a low radial artery-to-sheath size ratio as reported risk factors. A 2023 encyclopedia entry also describes RAO as impeding future interventions and potential use of the artery for hemodialysis fistulae or coronary bypass grafting.
Decoding the Disparity: Is It Ethnicity or Other Factors?
The observation that Japanese participants in the RAP and BEAT trial had a higher incidence of RAO prompts a deeper investigation into the potential reasons behind this disparity. While ethnicity might seem like a straightforward explanation, it's essential to consider other variables that could be at play.
- Smaller Radial Arteries: Japanese individuals tend to have smaller radial arteries compared to Caucasians. This could lead to a less favorable artery-to-sheath size ratio, increasing the risk of occlusion.
- Repeated Interventions: Japanese participants were more likely to undergo a second radial intervention, which could independently increase the risk of RAO due to repeated trauma to the artery.
- Antiplatelet Use: The use of antiplatelet medications, which help prevent blood clot formation, was lower in Japanese participants. This could be a contributing factor, as aspirin may prevent clot formation in the radial artery.
- Prolonged Hemostasis: The duration of hemostasis, or the time it takes for bleeding to stop, was significantly longer in Japanese patients. Extended compression of the radial artery is a known risk factor for RAO.
Risk Prediction and Anticoagulant Review
A study dated July 29, 2026, aims to identify independent risk factors for RAO after right transradial coronary angiography or PCI and to build a visualized nomogram for individualized risk prediction. A February 11, 2026, systematic review and meta-analysis examines the efficacy and safety of direct oral anticoagulants (DOACs) for preventing or resolving RAO after transradial access. A 2025 comprehensive review covers radial artery anatomy, RAO pathophysiology and diagnosis, and potential risk factors.
A Surrogate, Not a Direct Diameter Measurement
In the RAP and BEAT substudy of Japanese and non-Japanese patients, radial artery diameter was not measured. The authors therefore could not confirm a difference in artery diameter between the groups. They reported that the higher RAO rate with the GSS6Fr represented a strong surrogate for smaller radial arteries in Japanese patients, but it was not a direct measurement of diameter.
Rates Vary by Sheath Size and Assessment Time
A meta-analysis cited in a study of the Indian population reported RAO incidence ranging from 0% to 19.5% across sheath sizes: 0% with 4F, 2% with 5F, 11% with 6F, and 19.5% with 7F. A separate systematic review and meta-analysis found that reported incidence ranged from less than 1% to 33% and varied with when patency was assessed; its pooled figures were 7.7% within 24 hours and 5.5% after more than one week. These findings show that the reported rate differs with sheath size and assessment timing.
The Verdict: Confounded or Real? What Does This Mean for You?
While the RAP and BEAT trial results suggest a potential association between Japanese ethnicity and a higher risk of RAO, the presence of multiple confounding factors makes it difficult to draw definitive conclusions. Further research is needed to disentangle the complex interplay of factors contributing to RAO and determine whether ethnicity truly plays an independent role.
Toward Lower RAO Rates
A June 2025 SCAI resource describes RAO as a common complication after transradial coronary intervention that can hinder future procedures; it says incidence has decreased but remains a concern, particularly for certain risk groups. A March 2024 article says recent guidelines favor transradial procedures for elective and emergency coronary interventions and urges operators to adopt efficient strategies to achieve very low RAO rates. The supplied materials emphasize prevention and lower rates but do not specify which future strategy will prove most effective.